Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory diseases, today announced that the United States Food and Drug ...

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

and therefore should only be given to these patients if they are not adequately controlled on low or medium dose inhaled corticosteroids. The most promising prospect in GSK’s late stage ...

Taiwan’s Air Force said the officer was "inhaled by the engine for unknown reasons." She later was pronounced dead after life-saving efforts were unsuccessful. "In response to media reports ...

Once a week treatment with a corticosteroid was seen to lower some biomarkers of muscle damage and inflammation ... after six months of weekly treatment with prednisone at a dose of 0.75 to 1 mg/kg, ...

Treatment with oral or inhaled corticosteroids is not warranted for children without history of atopy or family history of asthma, but medium-dose inhaled corticosteroids or leukotriene inhibitors ...

Treasury Secretary Janet Yellen was asked if she has ever “inhaled” marijuana, and she confirmed that she did at one point. Yellen appeared on “The Late Show with Stephen Colbert” on ...

The inhaler options have broadened in recent years, with products on the market that include everything from the short-acting Proventil (albuterol) rescue inhaler to next-generation SMART meds that ...

low dose (0.025 mg), medium dose (0.05 mg), and high dose (0.1 mg). All subjects will receive a total of two intravitreal injections of OCU200 six weeks apart. Patient follow-up will take place up ...

Typically, your doctor will start you on a low dosage of Mounjaro and adjust it over time. They’ll ultimately prescribe the smallest dosage that provides the desired effect. The following ...